Patents by Inventor Kenneth Gary

Kenneth Gary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12514839
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: January 6, 2026
    Assignee: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Publication number: 20240156768
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Application
    Filed: January 19, 2024
    Publication date: May 16, 2024
    Applicant: Alcresta Therapeutics, Inc.
    Inventors: Robert GALLOTTO, Greta L. LORING, Kenneth GARY, Edward S. PARK, David J. BROWN, Willem Robert Klaas SCHOEVAART, Michiel Christian Alexander van VLIET
  • Patent number: 11944596
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: April 2, 2024
    Assignee: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Patent number: 11911357
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: February 27, 2024
    Assignee: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Publication number: 20210283085
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Application
    Filed: May 27, 2021
    Publication date: September 16, 2021
    Applicant: Alcresta Therapeutics, Inc.
    Inventors: Robert GALLOTTO, Greta L. LORING, Kenneth GARY, Edward S. PARK, David J. BROWN, Willem Robert Klaas SCHOEVAART, Michiel Christian Alexander van VLIET
  • Patent number: 11045440
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Grant
    Filed: February 27, 2019
    Date of Patent: June 29, 2021
    Assignee: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Publication number: 20190224155
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Application
    Filed: February 27, 2019
    Publication date: July 25, 2019
    Applicant: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Patent number: 10258590
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: April 16, 2019
    Assignee: Alcresta Therapeutics, Inc.
    Inventors: Robert Gallotto, Greta L. Loring, Kenneth Gary, Edward S. Park, David J. Brown, Willem Robert Klaas Schoevaart, Michiel Christian Alexander van Vliet
  • Publication number: 20170238851
    Abstract: Sensor systems, transdermal analyte monitoring systems (TAMS), and methods of improving analyte detection are described herein. The sensor systems have two working terminals, at least one counter terminal, and optionally one or more reference terminals. The first working terminal measures electrical signals due to an analyte level along with background interferences. The second working terminal measures only background interferences. The transdermal analyte monitoring systems include the sensor system and a computing device. The computing device performs mathematical analysis using an appropriate algorithm on the electrical information provided by the electrodes of the sensor system to obtain an accurate analyte level. Typically, the second electrical signal is subtracted from the first electrical signal to obtain an accurate analyte level in real time.
    Type: Application
    Filed: August 26, 2015
    Publication date: August 24, 2017
    Inventors: Eric V. Duhamel, Kenneth Gary
  • Publication number: 20170105903
    Abstract: Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.
    Type: Application
    Filed: October 12, 2016
    Publication date: April 20, 2017
    Applicant: ALCRESTA THERAPEUTICS, INC.
    Inventors: Robert GALLOTTO, Greta L. LORING, Kenneth GARY, Edward S. PARK, David J. BROWN, Willem Robert Klaas SCHOEVAART, Michiel Christian Alexander van VLIET
  • Publication number: 20120077277
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Application
    Filed: December 6, 2011
    Publication date: March 29, 2012
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 8080205
    Abstract: Analyte meter protectors, meters that include the same, and methods. In one example, a ketone monitoring system is provided wherein a port protector is used in combination with a meter.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: December 20, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Publication number: 20110253532
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Application
    Filed: February 24, 2011
    Publication date: October 20, 2011
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7914742
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: November 20, 2009
    Date of Patent: March 29, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7897107
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: March 1, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7867446
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: January 11, 2011
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7846388
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: December 7, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7846387
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: December 7, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7846386
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: December 7, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary
  • Patent number: 7846385
    Abstract: Analyte meter protectors, meters that include the same, and methods.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: December 7, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Frederic Arbogast, Paul Strasma, Lawrence Azzano, Kenneth Gary